Albumin (as Excipient) Market (Product Type: Human Serum Albumin and Recombinant Albumin; and Application: Human Serum Albumin and Recombinant Albumin) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Table of Contents

1. Preface

• 1.1. Report Scope and Market Segmentation
• 1.2. Research Highlights

2. Assumptions and Research Methodology

• 2.1. Assumptions and Acronyms Used
• 2.2. Research Methodology

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunity
• 4.3. Global Albumin (as Excipient) Market Forecast
• 4.4. Global Albumin (as Excipient) Market Outlook

5. Market Outlook

• 5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
• 5.2. Technological Advancement
• 5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type

• 6.1. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
• 6.2. Introduction
• 6.3. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
• 6.4. Global Albumin (as Excipient) Market Forecast, by Product Type
  • 6.4.1. Human Serum Albumin
  • 6.4.2. Recombinant Albumin
• 6.5. Global Albumin (as Excipient) Market Analysis, by Product Type

7. Global Albumin (as Excipient) Market Analysis and Forecast, by Application

• 7.1. Introduction
• 7.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
• 7.3. Global Albumin (as Excipient) Market Forecast, by Application
  • 7.3.1. Human Serum Albumin Applications
    • 7.3.1.1. Drug Formulation
    • 7.3.1.2. Drug Delivery
    • 7.3.1.3. Vaccines
    • 7.3.1.4. Medical Device Coating
    • 7.3.1.5. Culture Medium & Stabilizer
    • 7.3.1.6. Diagnostics
    • 7.3.1.7. In Vitro Fertilization
  • 7.3.2. Recombinant Albumin
    • 7.3.2.1. Drug Formulation
    • 7.3.2.2. Drug Delivery
    • 7.3.2.3. Vaccines
    • 7.3.2.4. Medical Device Coating
    • 7.3.2.5. Culture Medium & Stabilizer
    • 7.3.2.6. Diagnostics
    • 7.3.2.7. In Vitro Fertilization
• 7.4. Global Albumin (as Excipient) Market Analysis, by Application

8. Global Albumin (as Excipient) Market Analysis and Forecast, by End-user

• 8.1. Introduction
• 8.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
• 8.3. Global Albumin (as Excipient) Market Forecast, by End-user
  • 8.3.1. Pharmaceutical & Biotechnology Industry
  • 8.3.2. Research Institutes
  • 8.3.3. Others
• 8.4. Global Albumin (as Excipient) Market Analysis, by End-user

9. Global Albumin (as Excipient) Market Analysis and Forecast, by Region

• 9.1. Global Albumin (as Excipient) Market Analysis, by Region
• 9.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Region
• 9.3. Global Albumin (as Excipient) Market Forecast, by Region
  • 9.3.1. North America
  • 9.3.2. Europe
  • 9.3.3. Asia Pacific
  • 9.3.4. Latin America
  • 9.3.5. Middle East & Africa

10. North America Albumin (as Excipient) Market Analysis

• 10.1. North America Albumin (as Excipient) Market Overview
• 10.2. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Country
• 10.3. North America Albumin (as Excipient) Market Forecast, by Country
  • 10.3.1. U.S.
  • 10.3.2. Canada
• 10.4. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
• 10.5. North America Albumin (as Excipient) Market Forecast, by Product Type
  • 10.5.1. Human Serum Albumin
  • 10.5.2. Recombinant Albumin
• 10.6. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
• 10.7. North America Albumin (as Excipient) Market Forecast, by Application
  • 10.7.1. Human Serum Albumin Applications
    • 10.7.1.1. Drug Formulation
    • 10.7.1.2. Drug Delivery
    • 10.7.1.3. Vaccines
    • 10.7.1.4. Medical Device Coating
    • 10.7.1.5. Culture Medium & Stabilizer
    • 10.7.1.6. Diagnostics
    • 10.7.1.7. In Vitro Fertilization
  • 10.7.2. Recombinant Albumin
    • 10.7.2.1. Drug Formulation
    • 10.7.2.2. Drug Delivery
    • 10.7.2.3. Vaccines
    • 10.7.2.4. Medical Device Coating
    • 10.7.2.5. Culture Medium & Stabilizer
    • 10.7.2.6. Diagnostics
    • 10.7.2.7. In Vitro Fertilization
• 10.8. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
• 10.9. North America Albumin (as Excipient) Market Forecast, by End-user
  • 10.9.1. Pharmaceutical & Biotechnology Industry
  • 10.9.2. Research Institutes
  • 10.9.3. Others

11. Europe Albumin (as Excipient) Market Analysis

• 11.1. Europe Albumin (as Excipient) Market Overview
• 11.2. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
• 11.3. Europe Albumin (as Excipient) Market Forecast, by Countries/Sub-region
  • 11.3.1. Germany
  • 11.3.2. France
  • 11.3.3. U.K.
  • 11.3.4. Italy
  • 11.3.5. Spain
  • 11.3.6. Rest of Europe
• 11.4. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
• 11.5. Europe Albumin (as Excipient) Market Forecast, by Product Type
  • 11.5.1. Human Serum Albumin
  • 11.5.2. Recombinant Albumin
• 11.6. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
• 11.7. Europe Albumin (as Excipient) Market Forecast, by Application
  • 11.7.1. Human Serum Albumin Applications
    • 11.7.1.1. Drug Formulation
    • 11.7.1.2. Drug Delivery
    • 11.7.1.3. Vaccines
    • 11.7.1.4. Medical Device Coating
    • 11.7.1.5. Culture Medium & Stabilizer
    • 11.7.1.6. Diagnostics
    • 11.7.1.7. In Vitro Fertilization
  • 11.7.2. Recombinant Albumin
    • 11.7.2.1. Drug Formulation
    • 11.7.2.2. Drug Delivery
    • 11.7.2.3. Vaccines
    • 11.7.2.4. Medical Device Coating
    • 11.7.2.5. Culture Medium & Stabilizer
    • 11.7.2.6. Diagnostics
    • 11.7.2.7. In Vitro Fertilization
• 11.8. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
• 11.9. Europe Albumin (as Excipient) Market Forecast, by End-user
  • 11.9.1. Pharmaceutical & Biotechnology Industry
  • 11.9.2. Research Institutes
  • 11.9.3. Others

12. Asia Pacific Albumin (as Excipient) Market Analysis

• 12.1. Asia Pacific Albumin (as Excipient) Market Overview
• 12.2. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
• 12.3. Asia Pacific Albumin (as Excipient) Market Forecast, by Countries/Sub-region
  • 12.3.1. Japan
  • 12.3.2. China
  • 12.3.3. India
  • 12.3.4. Australia & New Zealand
  • 12.3.5. Rest of Asia Pacific
• 12.4. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
• 12.5. Asia Pacific Albumin (as Excipient) Market Forecast, by Product Type
  • 12.5.1. Human Serum Albumin
  • 12.5.2. Recombinant Albumin
• 12.6. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
• 12.7. Asia Pacific Albumin (as Excipient) Market Forecast, by Application
  • 12.7.1. Human Serum Albumin Applications
    • 12.7.1.1. Drug Formulation
    • 12.7.1.2. Drug Delivery
    • 12.7.1.3. Vaccines
    • 12.7.1.4. Medical Device Coating
    • 12.7.1.5. Culture Medium & Stabilizer
    • 12.7.1.6. Diagnostics
    • 12.7.1.7. In Vitro Fertilization
  • 12.7.2. Recombinant Albumin
    • 12.7.2.1. Drug Formulation
    • 12.7.2.2. Drug Delivery
    • 12.7.2.3. Vaccines
    • 12.7.2.4. Medical Device Coating
    • 12.7.2.5. Culture Medium & Stabilizer
    • 12.7.2.6. Diagnostics
    • 12.7.2.7. In Vitro Fertilization
• 12.8. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
• 12.9. Asia Pacific Albumin (as Excipient) Market Forecast, by End-user
  • 12.9.1. Pharmaceutical & Biotechnology Industry
  • 12.9.2. Research Institutes
  • 12.9.3. Others

13. Latin America Albumin (as Excipient) Market Analysis

• 13.1. Latin America Albumin (as Excipient) Market Overview
• 13.2. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
• 13.3. Latin America Albumin (as Excipient) Market Forecast, by Countries/Sub-region
  • 13.3.1. Brazil
  • 13.3.2. Mexico
  • 13.3.3. Rest of Latin America
• 13.4. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
• 13.5. Latin America Albumin (as Excipient) Market Forecast, by Product Type
  • 13.5.1. Human Serum Albumin
  • 13.5.2. Recombinant Albumin
• 13.6. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
• 13.7. Latin America Albumin (as Excipient) Market Forecast, by Application
  • 13.7.1. Human Serum Albumin Applications
    • 13.7.1.1. Drug Formulation
    • 13.7.1.2. Drug Delivery
    • 13.7.1.3. Vaccines
    • 13.7.1.4. Medical Device Coating
    • 13.7.1.5. Culture Medium & Stabilizer
    • 13.7.1.6. Diagnostics
    • 13.7.1.7. In Vitro Fertilization
  • 13.7.2. Recombinant Albumin
    • 13.7.2.1. Drug Formulation
    • 13.7.2.2. Drug Delivery
    • 13.7.2.3. Vaccines
    • 13.7.2.4. Medical Device Coating
    • 13.7.2.5. Culture Medium & Stabilizer
    • 13.7.2.6. Diagnostics
    • 13.7.2.7. In Vitro Fertilization
• 13.8. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
• 13.9. Latin America Albumin (as Excipient) Market Forecast, by End-user
  • 13.9.1. Pharmaceutical & Biotechnology Industry
  • 13.9.2. Research Institutes
  • 13.9.3. Others

14. Middle East & Africa Albumin (as Excipient) Market Analysis

• 14.1. Middle East & Africa Albumin (as Excipient) Market Overview
• 14.2. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
• 14.3. Middle East & Africa Albumin (as Excipient) Market Forecast, by Countries/Sub-region
  • 14.3.1. GCC Countries
  • 14.3.2. South Africa
  • 14.3.3. Rest of MEA
• 14.4. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
• 14.5. Middle East & Africa Albumin (as Excipient) Market Forecast, by Product Type
  • 14.5.1. Human Serum Albumin
  • 14.5.2. Recombinant Albumin
• 14.6. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
• 14.7. Middle East & Africa Albumin (as Excipient) Market Forecast, by Application
  • 14.7.1. Human Serum Albumin Applications
    • 14.7.1.1. Drug Formulation
    • 14.7.1.2. Drug Delivery
    • 14.7.1.3. Vaccines
    • 14.7.1.4. Medical Device Coating
    • 14.7.1.5. Culture Medium & Stabilizer
    • 14.7.1.6. Diagnostics
    • 14.7.1.7. In Vitro Fertilization
  • 14.7.2. Recombinant Albumin
    • 14.7.2.1. Drug Formulation
    • 14.7.2.2. Drug Delivery
    • 14.7.2.3. Vaccines
    • 14.7.2.4. Medical Device Coating
    • 14.7.2.5. Culture Medium & Stabilizer
    • 14.7.2.6. Diagnostics
    • 14.7.2.7. In Vitro Fertilization
• 14.8. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
• 14.9. Middle East & Africa Albumin (as Excipient) Market Forecast, by End-user
  • 14.9.1. Pharmaceutical & Biotechnology Industry
  • 14.9.2. Research Institutes
  • 14.9.3. Others

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (by tier and size of companies)
• 15.2. Market Share Analysis/Ranking, by Company, 2021
• 15.3. Company Profiles
  • 15.3.1. Albumedix Ltd.
    • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.1.2. Product Portfolio
    • 15.3.1.3. Financial Overview
    • 15.3.1.4. SWOT Analysis
    • 15.3.1.5. Strategic Overview
  • 15.3.2. Albumin Therapeutics, LLC (Albumin Bioscience)
    • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.2.2. Product Portfolio
    • 15.3.2.3. Financial Overview
    • 15.3.2.4. SWOT Analysis
    • 15.3.2.5. Strategic Overview
  • 15.3.3. Biotest AG
    • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.3.2. Product Portfolio
    • 15.3.3.3. Financial Overview
    • 15.3.3.4. SWOT Analysis
    • 15.3.3.5. Strategic Overview
  • 15.3.4. CSL Behring (CSL)
    • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.4.2. Product Portfolio
    • 15.3.4.3. Financial Overview
    • 15.3.4.4. SWOT Analysis
    • 15.3.4.5. Strategic Overview
  • 15.3.5. Grifols, S.A.
    • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.5.2. Product Portfolio
    • 15.3.5.3. Financial Overview
    • 15.3.5.4. SWOT Analysis
    • 15.3.5.5. Strategic Overview
  • 15.3.6. HiMedia Laboratories
    • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.6.2. Product Portfolio
    • 15.3.6.3. Financial Overview
    • 15.3.6.4. SWOT Analysis
    • 15.3.6.5. Strategic Overview
  • 15.3.7. InVitria
    • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.7.2. Product Portfolio
    • 15.3.7.3. Financial Overview
    • 15.3.7.4. SWOT Analysis
    • 15.3.7.5. Strategic Overview
  • 15.3.8. Medxbio Pte Ltd
    • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.8.2. Product Portfolio
    • 15.3.8.3. Financial Overview
    • 15.3.8.4. SWOT Analysis
    • 15.3.8.5. Strategic Overview
  • 15.3.9. Octapharma AG
    • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.9.2. Product Portfolio
    • 15.3.9.3. Financial Overview
    • 15.3.9.4. SWOT Analysis
    • 15.3.9.5. Strategic Overview
  • 15.3.10. RayBiotech, Inc.
    • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.10.2. Product Portfolio
    • 15.3.10.3. Financial Overview
    • 15.3.10.4. SWOT Analysis
    • 15.3.10.5. Strategic Overview
  • 15.3.11. SeraCare Life Sciences
    • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.11.2. Product Portfolio
    • 15.3.11.3. Financial Overview
    • 15.3.11.4. SWOT Analysis
    • 15.3.11.5. Strategic Overview
  • 15.3.12. Sigma-Aldrich Co. (Merck KGaA)
    • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.12.2. Product Portfolio
    • 15.3.12.3. Financial Overview
    • 15.3.12.4. SWOT Analysis
    • 15.3.12.5. Strategic Overview
  • 15.3.13. Takeda Pharmaceutical Company Limited (Shire)
    • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.13.2. Product Portfolio
    • 15.3.13.3. Financial Overview
    • 15.3.13.4. SWOT Analysis
    • 15.3.13.5. Strategic Overview

List of Tables

• Table 01: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
• Table 03: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application, 2017-2031
• Table 04: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application, 2017-2031
• Table 05: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 06: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 07: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 08: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 09: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 10: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Region, 2017-2031
• Table 11: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Region, 2017-2031
• Table 12: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 13: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
• Table 14: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 15: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
• Table 16: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 17: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 18: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 19: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 20: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 21: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 22: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
• Table 23: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 24: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
• Table 25: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 26: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 27: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 28: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 29: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 30: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 31: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
• Table 32: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 33: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
• Table 34: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 35: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 36: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 37: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 38: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 39: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 40: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
• Table 41: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 42: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
• Table 43: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 44: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 45: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 46: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 47: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 48: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 49: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
• Table 50: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
• Table 51: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
• Table 52: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 53: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
• Table 54: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 55: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
• Table 56: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

• Figure 01: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, 2017-2031
• Figure 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, 2017-2031
• Figure 03: Global Albumin (as Excipient) Market Value Share, by Product Type, 2021
• Figure 04: Global Albumin (as Excipient) Market Value Share, by End-user, 2021
• Figure 05: Global Albumin (as Excipient) Market Value Share, by Application (Human Serum Albumin Applications) (2021)
• Figure 06: Global Albumin (as Excipient) Market Value Share, by Region, 2021
• Figure 07: Global Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
• Figure 08: Global Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
• Figure 09: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Human Serum Albumin, 2017-2031
• Figure 10: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Recombinant Albumin, 2017-2031
• Figure 11: Global Albumin (as Excipient) Market Value Share Analysis, by Application, 2021 and 2031
• Figure 12: Global Albumin (as Excipient) Market Attractiveness, by Application, 2022-2031
• Figure 13: Global Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
• Figure 14: Global Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
• Figure 15: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Formulation, 2017-2031
• Figure 16: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Delivery, 2017-2031
• Figure 17: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Vaccines, 2017-2031
• Figure 18: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Medical Device Coating, 2017-2031
• Figure 19: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Culture Medium & Stabilizer, 2017-2031
• Figure 20: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Diagnostics, 2017-2031
• Figure 21: Global Albumin (as Excipient) Market Revenue (US$ Mn), by In Vitro Fertilization, 2017-2031
• Figure 22: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Formulation, 2017-2031
• Figure 23: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Delivery, 2017-2031
• Figure 24: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Vaccines, 2017-2031
• Figure 25: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Medical Device Coating, 2017-2031
• Figure 26: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Culture Medium & Stabilizer, 2017-2031
• Figure 27: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Diagnostics, 2017-2031
• Figure 28: Global Albumin (as Excipient) Market Revenue (US$ Mn), by In Vitro Fertilization, 2017-2031
• Figure 29: Global Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 30: Global Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
• Figure 31: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Industry, 2017-2031
• Figure 32: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Specialty Centers, 2017-2031
• Figure 33: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Others, 2017-2031
• Figure 34: Global Albumin (as Excipient) Market Value Share Analysis, by Region, 2021 and 2031
• Figure 35: Global Albumin (as Excipient) Market Attractiveness, by Region, 2022-2031
• Figure 36: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 37: North America Albumin (as Excipient) Market Value Share (%), by Country, 2021 and 2031
• Figure 38: North America Albumin (as Excipient) Market Attractiveness, by Country, 2022-2031
• Figure 39: North America Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
• Figure 40: North America Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
• Figure 41: North America Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
• Figure 42: North America Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
• Figure 43: North America Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
• Figure 44: North America Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
• Figure 45: North America Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 46: North America Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
• Figure 47: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 48: Europe Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
• Figure 49: Europe Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
• Figure 50: Europe Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
• Figure 51: Europe Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
• Figure 52: Europe Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
• Figure 53: Europe Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
• Figure 54: Europe Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
• Figure 55: Europe Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
• Figure 56: Europe Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 57: Europe Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
• Figure 58: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 59: Asia Pacific Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
• Figure 60: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
• Figure 61: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
• Figure 62: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
• Figure 63: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
• Figure 64: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
• Figure 65: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
• Figure 66: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
• Figure 67: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 68: Asia Pacific Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
• Figure 69: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 70: Latin America Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
• Figure 71: Latin America Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
• Figure 72: Latin America Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
• Figure 73: Latin America Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
• Figure 74: Latin America Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
• Figure 75: Latin America Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
• Figure 76: Latin America Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
• Figure 77: Latin America Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
• Figure 78: Latin America Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 79: Latin America Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
• Figure 80: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
• Figure 81: Middle East & Africa Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
• Figure 82: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
• Figure 83: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
• Figure 84: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
• Figure 85: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
• Figure 86: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
• Figure 87: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
• Figure 88: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
• Figure 89: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
• Figure 90: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
• Figure 91: Global Albumin (as Excipient) Market Share, by Company, 2021